Treace Medical Concepts Inc (TMCI) financials
Treace Medical Concepts revenue and earnings by year
Treace Medical Concepts's revenue was $213 million in the fiscal year to December 31, 2025, up 1.6% from the year before. Net income was -$59.0 million, -27.7% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 32.4% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 7 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 213 | 209 | 187 | 142 | 94 | 57 | 39 |
| Revenue growth | 1.6% | 11.9% | 31.9% | 50.2% | 64.6% | 45.5% | — |
| Gross profit | 170 | 168 | 152 | 116 | 78 | 45 | 32 |
| Gross margin | 79.8% | 80.4% | 81.2% | 82.0% | 82.1% | 78.3% | 80.6% |
| Operating income | -54 | -56 | -51 | -35 | -17 | 1 | -4 |
| Operating margin | -25.5% | -26.6% | -27.5% | -24.6% | -17.5% | 1.5% | -9.0% |
| Net income | -59 | -56 | -50 | -43 | -21 | -4 | -4 |
| Net margin | -27.7% | -26.6% | -26.5% | -30.2% | -21.8% | -6.4% | -10.8% |
| Diluted EPS | -$0.93 | -$0.90 | -$0.81 | -$0.77 | -$0.42 | -$0.13 | — |
| Free cash flow | -29 | -49 | -46 | -45 | -20 | -6 | -9 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open TMCI in Markets.
See also: TMCI returns
No forecast, no recommendation. This page describes Treace Medical Concepts Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.